CEO Joseph Hagan was paid $2,575,123 in fiscal year 2023, ↑ up 91.7% from fiscal year 2022, the 25th percentile of its disclosed peer group (SEC filing 0001193125-24-102883 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$2,575,123 ↑ Joseph Hagan total, FY2023 | 25th CEO pay percentile vs peers | — CEO-to-median pay ratio | 99.25% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Joseph Hagan | $615,800 | $0 | $88,000 | $1,528,091 | $332,532 | $0 | $9,900 | $2,575,123 |
| Chief Executive Officer | ||||||||
| Christopher Aker | 387,700 | 0 | 33,300 | 475,845 | 178,342 | 0 | 9,900 | 1,085,087 |
| Senior Vice President and General Counsel | ||||||||
| Cris Calsada | 390,000 | 0 | 33,300 | 455,674 | 179,400 | 0 | 9,900 | 1,068,174 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Joseph Hagan | $2,575,123 | $1,343,238 | — | ↑ +1,231,885 |
| Christopher Aker | 1,085,087 | 651,543 | — | ↑ +433,544 |
| Cris Calsada | 1,068,174 | 627,619 | — | ↑ +440,555 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Regulus Therapeutics's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper RGLS reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
The list of companies that name RGLS as a peer is temporarily unavailable — recheck shortly.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2023 total |
|---|---|---|
| Alice S. Huang, Ph.D | Independent Director | $93,441 |
| David Baltimore, Ph.D | Independent Director | $95,441 |
| Hugh Rosen, M.D., Ph.D | Independent Director | $93,441 |
| Jake R. Nunn | Independent Director | $97,441 |
| Kathryn J. Collier | Independent Director | $107,441 |
| Pascale Witz | Independent Director | $93,441 |
| Preston S. Klassen, M.D | Director | — |
| Stelios Papadopoulos, Ph.D | Chair of the Board | $131,441 |
| William H. Rastetter, Ph.D | Independent Director | $99,441 |
Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Christopher Aker | Sr. VP & General Counsel | 2025-01-09 | A | 66,625 | $1 | $90,610 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-09 | A | 21,000 | 1 | 27,300 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-09 | A | 30,000 | 1 | 39,000 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-09 | A | 37,500 | 1 | 51,000 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-09 | A | 17,500 | 1 | 22,750 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-09 | A | 62,500 | 1 | 85,000 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-09 | A | 62,000 | 1 | 80,600 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-09 | A | 218,750 | 1 | 297,500 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-13 | D | 31,445 | 1 | 39,721 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-13 | D | 38,716 | 1 | 48,906 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-13 | D | 38,547 | 1 | 48,693 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-13 | D | 115,290 | 1 | 145,634 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-14 | D | 5,088 | 1 | 6,427 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-14 | D | 5,088 | 1 | 6,427 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-14 | D | 11,764 | 1 | 14,860 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-30 | A | 50,000 | 1 | 54,260 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-30 | A | 562,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-01-30 | A | 19,610 | 1 | 20,787 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-30 | A | 675,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-30 | A | 1,350,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-30 | A | 487,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-03 | A | 12,000 | 8 | 95,852 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-16 | A | 1,396 | 10 | 13,820 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2025-06-16 | — | 1,396 | — | — | 1 insider, 1 accrual row | ||
| Kathryn J. Collier | Director | 2025-06-17 | D | 2,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | A | 2,325 | 9 | 20,460 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | A | 2,604 | 10 | 25,780 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | D | 2,604 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 375,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 45,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 677 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 44,264 | — | — | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 249,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 27,377 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 27,377 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 5,208 | — | — | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 64,635 | — | — | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 562,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 462,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 5,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 48,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 62,500 | — | — | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 5,208 | — | — | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 6,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 571,558 | — | — | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 45,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 7,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 21,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 33,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 2,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 115,555 | — | — | Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 6,979 | — | — | Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 487,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 120,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 85,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 2,976 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 160,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,350,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 990,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,312,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 67,233 | — | — | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 140,228 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 393,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 675,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 363,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 70,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 60,796 | — | — | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 528,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 350,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 59,514 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 976,253 | — | — | Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 21,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 75,565 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 48,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 83,125 | — | — | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 225,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Christopher Aker | Sr. VP & General Counsel | 2025-01-09 | A | 66,625 | $1 | $90,610 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-09 | A | 21,000 | 1 | 27,300 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-09 | A | 30,000 | 1 | 39,000 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-09 | A | 37,500 | 1 | 51,000 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-09 | A | 17,500 | 1 | 22,750 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-09 | A | 62,500 | 1 | 85,000 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-09 | A | 62,000 | 1 | 80,600 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-09 | A | 218,750 | 1 | 297,500 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-13 | D | 31,445 | 1 | 39,721 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-13 | D | 38,716 | 1 | 48,906 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-13 | D | 38,547 | 1 | 48,693 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-13 | D | 115,290 | 1 | 145,634 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-14 | D | 5,088 | 1 | 6,427 | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-14 | D | 5,088 | 1 | 6,427 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-14 | D | 11,764 | 1 | 14,860 | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-30 | A | 50,000 | 1 | 54,260 | Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-01-30 | A | 562,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-01-30 | A | 19,610 | 1 | 20,787 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-01-30 | A | 675,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-01-30 | A | 1,350,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-01-30 | A | 487,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-04-30 | A | 62,500 | 0 | 0 | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-03 | A | 12,000 | 8 | 95,852 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-16 | A | 1,396 | 10 | 13,820 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-16 | D | 1,396 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | D | 2,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | A | 2,325 | 9 | 20,460 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | A | 2,604 | 10 | 25,780 | Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-17 | D | 2,604 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 375,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 45,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 677 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 44,264 | — | — | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 249,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 27,377 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 27,377 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 5,208 | — | — | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 64,635 | — | — | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 562,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 462,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 5,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 48,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 62,500 | — | — | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 5,208 | — | — | Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 6,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 571,558 | — | — | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 45,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 7,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 21,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 33,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 2,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 115,555 | — | — | Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 6,979 | — | — | Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 487,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 120,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 85,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 2,976 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 160,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,350,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 990,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 1,312,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Joseph P. Hagan | Director | 2025-06-25 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 67,233 | — | — | Common | Form 4 ↗ |
| Pascale Witz | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 140,228 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 393,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 675,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 4,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 363,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 70,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 60,796 | — | — | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 528,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 350,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Hugh Rosen | Director | 2025-06-25 | D | 57,292 | — | — | Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 59,514 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stelios Papadopoulos | Director | 2025-06-25 | D | 976,253 | — | — | Common | Form 4 ↗ |
| William H. Rastetter | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cris Calsada | Chief Financial Officer | 2025-06-25 | D | 21,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Kathryn J. Collier | Director | 2025-06-25 | D | 75,565 | — | — | Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 2,325 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Alice Shih-hou Huang | Director | 2025-06-25 | D | 4,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jake R. Nunn | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 60,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 30,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| David Baltimore | Director | 2025-06-25 | D | 9,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 48,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher Aker | Sr. VP & General Counsel | 2025-06-25 | D | 83,125 | — | — | Common | Form 4 ↗ |
| Preston Klassen | Director | 2025-06-25 | D | 225,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Joseph Hagan | PSU | 30,000 | — | $38,400 |
| Christopher Aker | Option | 437 | 13.1 | — |
| Christopher Aker | PSU | 11,250 | — | 14,400 |
| Joseph Hagan | Option | 29,999 | 13.1 | — |
| Joseph Hagan | Option | 1,000 | 9.5 | — |
| Christopher Aker | Option | 750 | 9.5 | — |
| Christopher Aker | Option | 33,500 | 6.4 | — |
| Christopher Aker | Option | 4,875 | 15.9 | — |
| Christopher Aker | Option | 24,997 | 2.6 | — |
| Christopher Aker | Option | 34,688 | 1.48 | — |
| Christopher Aker | Option | 360,938 | 1.36 | — |
| Cris Calsada | Option | 21,000 | 6.4 | — |
| Cris Calsada | PSU | 11,250 | — | 14,400 |
| Cris Calsada | Option | 24,997 | 2.6 | — |
| Cris Calsada | Option | 312 | 13.1 | — |
| Christopher Aker | Option | 7,000 | 13.1 | — |
| Cris Calsada | Option | 5,000 | 13.1 | — |
| Joseph Hagan | Option | 77,084 | 1.48 | — |
| Joseph Hagan | PSU | 437,500 | — | 560,000 |
| Christopher Aker | PSU | 131,250 | — | 168,000 |
| Cris Calsada | PSU | 125,000 | — | 160,000 |
| Joseph Hagan | Option | 6,500 | 9.5 | — |
| Joseph Hagan | Option | 99,999 | 6.4 | — |
| Joseph Hagan | Option | 1,875 | 13.1 | — |
| Joseph Hagan | Option | 16,250 | 15.9 | — |
| Joseph Hagan | Option | 83,327 | 2.6 | — |
| Joseph Hagan | Option | 1,203,126 | 1.36 | — |
| Christopher Aker | Option | 2,500 | 9.5 | — |
| Cris Calsada | Option | 10,000 | 6.2 | — |
| Cris Calsada | Option | 4,056 | 15.9 | — |
| Cris Calsada | Option | 24,688 | 1.48 | — |
| Cris Calsada | Option | 343,751 | 1.36 | — |
Our executive compensation program is designed to reward achievement of the specific strategic goals that we believe will advance our business strategy and create long-term value for our stockholders. Consistent with our goal of attracting, motivating and retaining a high-caliber executive team, our executive compensation program is designed to pay for performance.
| CEO STI target (% of salary) | 60% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon/Radford |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2024 | 2024-05-16 | 38,219,586 | 223,139 | 66,215 | 99.25% | Passed |
| 2023 | 2023-06-13 | 12,652,198 | 334,628 | 32,964 | 97.42% | Passed |
| 2022 | 2022-06-09 | 74,847,744 | 4,844,630 | 563,724 | 93.92% | Passed |
| 2021 | 2021-06-14 | 32,643,580 | 1,013,000 | 81,793 | 96.76% | Passed |
| 2020 | 2020-06-17 | 7,956,601 | 2,107,967 | 24,574 | 79.06% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2024 | 2024-05-16 | 99.25%a |
| 2023 | 2023-06-13 | 97.42%b |
| 2022 | 2022-06-09 | 93.92%c |
a. Approved under the standard stated in the filing — “Abstentions will be counted towards the vote total for Proposal 4 and will have the same effect as votes Against each of the proposed voting frequencies.”.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Stelios Papadopoulos, Ph.DIndependent · Board Chair · Nominating/Governance | $84,000 | $0 | $47,441 | — | $0 | $131,441 |
| Kathryn J. CollierIndependent · Compensation (Chair) | 60,000 | 0 | 47,441 | — | 0 | 107,441 |
| William H. Rastetter, Ph.DIndependent · Compensation | 52,000 | 0 | 47,441 | — | 0 | 99,441 |
| Jake R. NunnIndependent · Audit | 50,000 | 0 | 47,441 | — | 0 | 97,441 |
| David Baltimore, Ph.DIndependent · Nominating/Governance (Chair) | 48,000 | 0 | 47,441 | — | 0 | 95,441 |
| Pascale WitzIndependent · Audit | 46,000 | 0 | 47,441 | — | 0 | 93,441 |
| Hugh Rosen, M.D., Ph.DIndependent · Nominating/Governance | 46,000 | 0 | 47,441 | — | 0 | 93,441 |
| Alice S. Huang, Ph.DIndependent · Audit | 46,000 | 0 | 47,441 | — | 0 | 93,441 |
| Joseph P. HaganEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Preston S. Klassen, M.DEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 6,000 / 4,000 |
| Stock ownership guideline | — |
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $432,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $432,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Regulus Therapeutics names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Regulus Therapeutics.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Corvus Pharmaceuticals | 2025 | Richard Miller | $36,566 | $0 | $6,989,000 | $0 | $7,031,566 |
| 2 | aTyr Pharma | 2025 | Sanjay Shukla | 638,977 | 0 | 2,595,200 | 210,862 | 3,456,253 |
| 3 | Rezolute | 2025 | Nevan Charles Elam | 610,825 | 1,767,204 | 0 | 0 | 2,851,109 |
| 4 | Regulus Therapeutics | 2023 | Joseph Hagan | 615,800 | 88,000 | 1,528,091 | 332,532 | 2,575,123 |
| 5 | Lineage Cell Therapeutics | 2025 | Brian Culley | 691,800 | 0 | 882,970 | 518,900 | 2,111,170 |
| — | BioCardia | — | — | — | — | — | — | not in coverage universe |
| — | Pulmatrix | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Regulus Therapeutics | not disclosed | not disclosed | No | Aon/Radford |
| aTyr Pharma | 60% (Committee lowered payout from 75% achievement to 60% given EFZO-FIT study results)% | Option 100 | not disclosed | Radford |
| BioCardia | not disclosed | not disclosed | not disclosed | not disclosed |
| Corvus Pharmaceuticals | not disclosed | Option 100 | not disclosed | not disclosed |
| Lineage Cell Therapeutics | not disclosed | not disclosed | not disclosed | Anderson |
| Pulmatrix | not disclosed | not disclosed | not disclosed | not disclosed |
| Rezolute | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Joseph Hagan | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Summary Compensation Table”. As printed: 2,575,123. Filing ↗machine: t54 · r2 · c27 · span 187482–187491 |
| 2 | Section 01, Christopher Aker | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Summary Compensation Table”. As printed: 1,085,087. Filing ↗machine: t54 · r5 · c27 · span 190505–190514 |
| 3 | Section 01, Cris Calsada | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Summary Compensation Table”. As printed: 1,068,174. Filing ↗machine: t54 · r8 · c27 · span 193527–193536 |
| 4 | Section 08, Stelios Papadopoulos, Ph.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 131,441. Filing ↗machine: span 348693–348700 |
| 5 | Section 08, Kathryn J. Collier | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 107,441. Filing ↗machine: t108 · r3 · c11 · span 346457–346464 |
| 6 | Section 08, William H. Rastetter, Ph.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 99,441. Filing ↗machine: span 349435–349441 |
| 7 | Section 08, Jake R. Nunn | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 97,441. Filing ↗machine: t108 · r5 · c11 · span 347934–347940 |
| 8 | Section 08, David Baltimore, Ph.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 95,441. Filing ↗machine: span 345725–345731 |
| 9 | Section 08, Pascale Witz | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 93,441. Filing ↗machine: t108 · r9 · c11 · span 350916–350922 |
| 10 | Section 08, Hugh Rosen, M.D., Ph.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 93,441. Filing ↗machine: span 350190–350196 |
| 11 | Section 08, Alice S. Huang, Ph.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 93,441. Filing ↗machine: span 347211–347217 |
| 12 | Section 08, Joseph P. Hagan | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 08, Preston S. Klassen, M.D | DEF 14A | 2024-04-19 | 0001193125-24-102883 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 14 | Section 02, Christopher Aker 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004270 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 15 | Section 02, Cris Calsada 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004272 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 16 | Section 02, Preston Klassen 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004269 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Preston Klassen 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004269 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Christopher Aker 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004270 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Cris Calsada 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004272 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Joseph P. Hagan 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004274 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Joseph P. Hagan 2025-01-09 | Form 4 | 2025-01-10 | 0000950170-25-004274 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Preston Klassen 2025-01-13 | Form 4 | 2025-01-15 | 0000950170-25-005880 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Cris Calsada 2025-01-13 | Form 4 | 2025-01-15 | 0000950170-25-005881 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Christopher Aker 2025-01-13 | Form 4 | 2025-01-15 | 0000950170-25-005882 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Joseph P. Hagan 2025-01-13 | Form 4 | 2025-01-15 | 0000950170-25-005883 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Cris Calsada 2025-01-14 | Form 4 | 2025-01-15 | 0000950170-25-005881 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Christopher Aker 2025-01-14 | Form 4 | 2025-01-15 | 0000950170-25-005882 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Joseph P. Hagan 2025-01-14 | Form 4 | 2025-01-15 | 0000950170-25-005883 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Joseph P. Hagan 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011853 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Cris Calsada 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011848 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, David Baltimore 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011850 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Preston Klassen 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011851 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Joseph P. Hagan 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011853 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Christopher Aker 2025-01-30 | Form 4 | 2025-01-31 | 0000950170-25-011849 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, William H. Rastetter 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061111 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Hugh Rosen 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Kathryn J. Collier 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061114 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Alice Shih-hou Huang 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061117 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, David Baltimore 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061118 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, David Baltimore 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061118 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Jake R. Nunn 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061298 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Pascale Witz 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061115 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Alice Shih-hou Huang 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061117 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Stelios Papadopoulos 2025-04-30 | Form 4 | 2025-04-30 | 0000950170-25-061119 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Preston Klassen 2025-06-03 | Form 4 | 2025-06-04 | 0000950170-25-081715 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Kathryn J. Collier 2025-06-16 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Kathryn J. Collier 2025-06-16 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Kathryn J. Collier 2025-06-17 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Kathryn J. Collier 2025-06-17 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Kathryn J. Collier 2025-06-17 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Kathryn J. Collier 2025-06-17 | Form 4 | 2025-06-18 | 0000950170-25-087947 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Joseph P. Hagan 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Pascale Witz 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091035 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 150 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 151 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 152 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 153 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 154 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 155 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 156 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 157 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 158 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 159 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 160 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 161 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 162 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 163 | Section 02, Hugh Rosen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 164 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 165 | Section 02, Stelios Papadopoulos 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 166 | Section 02, William H. Rastetter 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091036 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 167 | Section 02, Cris Calsada 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 168 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 169 | Section 02, Kathryn J. Collier 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-090992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 170 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 171 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 172 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 173 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 174 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 175 | Section 02, Alice Shih-hou Huang 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 176 | Section 02, Jake R. Nunn 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 177 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 178 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 179 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 180 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 181 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 182 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 183 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 184 | Section 02, David Baltimore 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 185 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 186 | Section 02, Christopher Aker 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091019 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 187 | Section 02, Preston Klassen 2025-06-25 | Form 4 | 2025-06-27 | 0000950170-25-091020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 188 | Section 06, 2024 vote | Form 8-K | 2024-05-17 | 0001193125-24-141703 | Item 5.07 · say-on-pay result. As reported: 99.25% (votes for as printed: 38,219,586). Filing ↗ |
| 189 | Section 06, 2023 vote | Form 8-K | 2023-06-14 | 0001193125-23-166837 | Item 5.07 · say-on-pay result. As reported: 97.42% (votes for as printed: 12,652,198). Filing ↗ |
| 190 | Section 06, 2022 vote | Form 8-K | 2022-06-13 | 0001193125-22-172905 | Item 5.07 · say-on-pay result. As reported: 93.92%. Filing ↗ |
| 191 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 192 | Section 09b board cost (computed) | Computed | — | — | Cash 432,000 + equity 0 + all other 0 = 432,000, summed across the director compensation table rows.machine: formula: Σ = 432,000 |
| 193 | Corvus Pharmaceuticals, Section 10b CEO total | DEF 14A | 2026-04-24 | 0001104659-26-048595 | CEO total compensation as printed in Corvus Pharmaceuticals's own proxy. As printed: 7,031,566. Filing ↗ |
| 194 | aTyr Pharma, Section 10b CEO total | DEF 14A | 2026-03-26 | 0001339970-26-000021 | CEO total compensation as printed in aTyr Pharma's own proxy. As printed: 3,456,253. Filing ↗machine: r2 · c21 · span 533754–533763 |
| 195 | Rezolute, Section 10b CEO total | DEF 14A | 2025-10-07 | 0001104659-25-097509 | CEO total compensation as printed in Rezolute's own proxy. As printed: 2,851,109. Filing ↗ |
| 196 | Regulus Therapeutics (subject), Section 10b CEO total | DEF 14A | 2024-04-19 | 0001193125-24-102883 | CEO total compensation as printed in Regulus Therapeutics's own proxy. As printed: 2,575,123. Filing ↗machine: t54 · r2 · c27 · span 187482–187491 |
| 197 | Lineage Cell Therapeutics, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191556 | CEO total compensation as printed in Lineage Cell Therapeutics's own proxy. As printed: 2,111,170. Filing ↗machine: span 377951–377960 |
| 198 | Section 10a, aTyr Pharma reciprocity | DEF 14A | — | 0001339970-26-000021 | aTyr Pharma's most recent proxy was read; its disclosed peer group does not include Regulus Therapeutics. Filing ↗ |
| 199 | Section 10a, Lineage Cell Therapeutics reciprocity | DEF 14A | — | 0001193125-26-191556 | Lineage Cell Therapeutics's most recent proxy was read; its disclosed peer group does not include Regulus Therapeutics. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.